Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene
- PMID: 17407387
- PMCID: PMC1845156
- DOI: 10.1371/journal.pmed.0040118
Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene
Abstract
Background: Macrosomia is associated with considerable neonatal and maternal morbidity. Factors that predict macrosomia are poorly understood. The increased rate of macrosomia in the offspring of pregnant women with diabetes and in congenital hyperinsulinaemia is mediated by increased foetal insulin secretion. We assessed the in utero and neonatal role of two key regulators of pancreatic insulin secretion by studying birthweight and the incidence of neonatal hypoglycaemia in patients with heterozygous mutations in the maturity-onset diabetes of the young (MODY) genes HNF4A (encoding HNF-4alpha) and HNF1A/TCF1 (encoding HNF-1alpha), and the effect of pancreatic deletion of Hnf4a on foetal and neonatal insulin secretion in mice.
Methods and findings: We examined birthweight and hypoglycaemia in 108 patients from families with diabetes due to HNF4A mutations, and 134 patients from families with HNF1A mutations. Birthweight was increased by a median of 790 g in HNF4A-mutation carriers compared to non-mutation family members (p < 0.001); 56% (30/54) of HNF4A-mutation carriers were macrosomic compared with 13% (7/54) of non-mutation family members (p < 0.001). Transient hypoglycaemia was reported in 8/54 infants with heterozygous HNF4A mutations, but was reported in none of 54 non-mutation carriers (p = 0.003). There was documented hyperinsulinaemia in three cases. Birthweight and prevalence of neonatal hypoglycaemia were not increased in HNF1A-mutation carriers. Mice with pancreatic beta-cell deletion of Hnf4a had hyperinsulinaemia in utero and hyperinsulinaemic hypoglycaemia at birth.
Conclusions: HNF4A mutations are associated with a considerable increase in birthweight and macrosomia, and are a novel cause of neonatal hypoglycaemia. This study establishes a key role for HNF4A in determining foetal birthweight, and uncovers an unanticipated feature of the natural history of HNF4A-deficient diabetes, with hyperinsulinaemia at birth evolving to decreased insulin secretion and diabetes later in life.
Conflict of interest statement
Figures
Comment in
-
Type 2 diabetes: hypoinsulinism, hyperinsulinism, or both?PLoS Med. 2007 Apr;4(4):e148. doi: 10.1371/journal.pmed.0040148. PLoS Med. 2007. PMID: 17407388 Free PMC article.
-
Macrosomia and neonatal hypoglycaemia in RW pedigree subjects with a mutation (Q268X) in the gene encoding hepatocyte nuclear factor 4alpha (HNF4A).Diabetologia. 2007 Dec;50(12):2600-1. doi: 10.1007/s00125-007-0833-7. Epub 2007 Sep 22. Diabetologia. 2007. PMID: 17891372 No abstract available.
References
-
- American College of Obstetricians and Gynecologists (ACOG) ACOG Practice Bulletin no. 22. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2000. Fetal macrosomia. 11 November 2000.
-
- Chauhan SP, Grobman WA, Gherman RA, Chauhan VB, Chang G, et al. Suspicion and treatment of the macrosomic fetus: A review. Am J Obstet Gynecol. 2005;193:332–346. - PubMed
-
- Thomas PM, Cote GJ, Wohllk N, Haddad B, Mathew PM, et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science. 1995;268:426–429. - PubMed
-
- Thomas P, Ye Y, Lightner E. Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum Mol Genet. 1996;5:1809–1812. - PubMed
-
- Dunne MJ, Kane C, Shepherd RM, Sanchez JA, James RF, et al. Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med. 1997;336:703–706. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
